oncology American Society of Clinical Oncology (ASCO) 2026 Annual Meeting: Expert Interview Dr. Pimentel Muniz — Length: 04:02 Long-term Data Renews Emphasis on Fixed-dose Combination in Unresectable or Metastatic Melanoma Watch Presentation
oncology American Society of Clinical Oncology (ASCO) 2026 Annual Meeting May 29 – June 2, 2026 — Chicago, Illinois Fixed Combination of Checkpoint Inhibitors Maintain PFS and OS Advantage at 5 Years Download 4 PowerPoint slides
oncology Prostate Cancer: Expert Interview Dr. Frédéric Pouliot — Length: 09:00 Bridging Data from the VISION Clinical Trial to Real-world Experience: 177Lu in mCRPC Watch Presentation
Hematology 65th American Society of Hematology (ASH) Annual Meeting Dr. Brown & Dr. Sehn — Length: 07:48 Extended ALPINE Trial Results Show Persistent Advantage of Second-generation BTK Inhibitor Watch Presentation
Hematology 65th American Society of Hematology (ASH) Annual Meeting Dr. Tam & Dr. Johnson — Length: 06:58 Synergistic Approach: Promising Results of a Novel Combination Therapy for CLL/SLL Patients Watch Presentation
Hematology 65th American Society of Hematology (ASH) Annual Meeting Dr. Shadman & Dr. Hillis — Length: 08:18 Intolerance Trial: Differences in Adverse Events Among Second-generation BTK Inhibitors Watch Presentation
oncology Prostate Cancer: Expert Discussion Dr. Fred Saad & Dr. Michael Kolinsky — Length: 09:03 Strategies for Prolonging Survival: Treatment Intensification & PARP Inhibitors in mCRPC Watch Presentation
oncology Chronic Graft-versus-host Disease: Expert Interview Dr. Dennis Kim — Length: 07:00 Clinical Application of Extracorporeal Photopheresis for Treatment of Chronic Graft-versus-host Disease Watch Presentation
Hematology European Hematology Association (EHA) 2023 Hybrid Congress June 8-11, 2023 — Frankfurt, Germany Long-term Efficacy in CLL: Expanding Evidence Across Treatment-naïve and Relapsed/Refractory Patients Download 3 PowerPoint slides
Hematology European Hematology Association (EHA) 2023 Congress: Expert Interview Dr. Talha Munir — Length: 04:16 SEQUOIA Extended Follow-up: Reinforced Front-Line Effectiveness of Second-Generation BTK Inhibitor Watch Presentation
Hematology American Society of Clinical Oncology (ASCO) 2023 Annual Meeting June 2-6, 2023 — Chicago, Illinois BTK Inhibitors Differentiated on Safety and Efficacy in CLL Download 4 PowerPoint slides
Hematology Allogeneic Stem Cell Transplantation: Expert Review and Commentary Dr. Mattias Stelljes, Dr. Thomas J. Nevill & Dr. Victor Lewis Conditioning for Allogeneic Hematopoietic Stem Cell: Strategies Compared Download 2 PowerPoint slides